Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Crit Care Med. 2023 Nov 1;52(3):407–419. doi: 10.1097/CCM.0000000000006092

Table 3:

Sepsis/Pneumonia vs. other ARDS etiologies

28-Day Mortality
ARDS Etiologies Metabolic, No. (%) Control, No. (%) Unadjusted OR (95% CI) Adjusted ORa(95% CI) P-valuec Unadjusted Interaction P-valued Adjusted Interaction P-valued
Sepsis/Pneumonia 82 (22.5) 783 (27.6) 0.76 (0.59–0.99) 0.64 (0.48–0.84) 0.001 0.02 0.04
Other Etiologies 24 (26.7) 194 (19.5) 1.50 (0.92–2.45) 1.18 (0.70–1.99) 0.546
90-Day Mortality
ARDS Etiologies Metabolic, No. (%) Control, No. (%) Unadjusted OR (95% CI) Adjusted ORa (95% CI) P-valuec Unadjusted Interaction P-valued Adjusted Interaction P-valued
Sepsis/Pneumonia 103 (28.3) 919 (32.4) 0.83 (0.65–1.05) 0.69 (0.53–0.89) 0.005 <0.01 0.02
Other Etiologies 31 (34.4) 237 (23.9) 1.68 (1.06–2.65) 1.26 (0.77–2.06) 0.366
a

Multivariable logistic regression model adjusted for age, sex, race, ethnicity, comorbidities, and treatment group assignment.

b

Other ARDS etiologies include all primary etiologies other than sepsis or pneumonia.

c

P-value for adjusted analyses comparing metabolic to control.

d

P-values for comparing the interaction between metabolic and control across the two ARDS etiology strata of sepsis/pneumonia and other ARDS etiology. OR=Odds Ratio.